...
首页> 外文期刊>Chemico-biological interactions >beta-cell regenerative efficacy of a polysaccharide isolated from methanolic extract of Tinospora cordifolia stem on streptozotocin -induced diabetic Wistar rats
【24h】

beta-cell regenerative efficacy of a polysaccharide isolated from methanolic extract of Tinospora cordifolia stem on streptozotocin -induced diabetic Wistar rats

机译:堇青叶茎部甲醇提取物分离的多糖对链脲佐菌素诱导的糖尿病Wistar大鼠的β细胞再生功效

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The use of herbal supplements either as extracts or plant-derived individual molecules has significantly increased in the process of drug discovery and development for their potential efficacy or reduced risk in treating human disorders. Tinospora cordifolia (T. cordifolia) is a widely used herbal source to treat various human ailments, including diabetes mellitus. The present study was aimed on evaluating the antidiabetic property of a novel polysaccharide isolated from the methanolic extract of T. cordifolia stem. Bioassay guided fractionation was followed to isolate a compound from the methanol extract. The compound was administered orally at a dose of 20 mg/kg.b.wt for 60 days to control and STZ-induced diabetic male Wistar rats. It was found that plasma glucose was significantly (p < 0.05) reduced compared to normal. Oral administration of the compound significantly decreased HBA1c, triglycerides and total cholesterol and at the same time markedly increased hemoglobin, tissue glycogen and HDL cholesterol. Also the compounds restored the altered carbohydrate metabolizing enzymes, insulin, C-peptide, C-14-glucose oxidation levels to near normal. In addition, the histological studies revealed that there was regeneration of beta-cells in the pancreatic sections. The expression of Glut-4 mRNA and protein in the gasrtocnemius muscle were significantly enhanced after the compound treatment. These results confirm that the novel polysaccharide possesses hypoglycemic, glucose oxidizing, hypolipidemic and beta-cell regenerative properties and hence it could be developed into potential oral hypoglycemic drug with lesser side effects. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
机译:在药物发现和开发过程中,由于其潜在的功效或降低的治疗人类疾病的风险,草药补充剂作为提取物或植物来源的单个分子的使用已显着增加。 Tinospora cordifolia(T. cordifolia)是广泛用于治疗包括糖尿病在内的各种人类疾病的草药来源。本研究的目的是评估一种新的多糖的抗糖尿病特性,该多糖是从T. cordifolia茎的甲醇提取物中分离得到的。进行生物测定指导的分级分离,以从甲醇提取物中分离出化合物。将该化合物以20mg / kg.b.wt的剂量口服给药60天,以控制和STZ诱导的糖尿病雄性Wistar大鼠。发现血浆葡萄糖与正常相比显着降低(p <0.05)。口服该化合物可显着降低HBA1c,甘油三酸酯和总胆固醇,同时显着增加血红蛋白,组织糖原和HDL胆固醇。该化合物还使改变的碳水化合物代谢酶,胰岛素,C-肽,C-14-葡萄糖氧化水平恢复到接近正常水平。另外,组织学研究表明在胰腺切片中存在β细胞的再生。复方治疗后,腓肠肌中Glut-4 mRNA和蛋白的表达明显增强。这些结果证实了该新型多糖具有降血糖,葡萄糖氧化,降血脂和β细胞再生的特性,因此可以被开发为潜在的口服降血糖药物,副作用较小。 (C)2015 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号